GR3024291T3 - Beta-carboline derivatives, ligands of benzodiazepine receptors with inverse agonist and benzodiazepine antagonist effects and medicaments containing them - Google Patents

Beta-carboline derivatives, ligands of benzodiazepine receptors with inverse agonist and benzodiazepine antagonist effects and medicaments containing them

Info

Publication number
GR3024291T3
GR3024291T3 GR970401940T GR970401940T GR3024291T3 GR 3024291 T3 GR3024291 T3 GR 3024291T3 GR 970401940 T GR970401940 T GR 970401940T GR 970401940 T GR970401940 T GR 970401940T GR 3024291 T3 GR3024291 T3 GR 3024291T3
Authority
GR
Greece
Prior art keywords
radical
beta
benzodiazepine
hydroxyl
ligands
Prior art date
Application number
GR970401940T
Other languages
English (en)
Inventor
Robert Dodd
Pierre Potier
Jean Rossier
Gilbert Dorey
Laurent Dubois
De Carvalho Lia Prado
Original Assignee
Centre Nat Rech Scient
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre Nat Rech Scient filed Critical Centre Nat Rech Scient
Publication of GR3024291T3 publication Critical patent/GR3024291T3/el

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/14Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Anesthesiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
GR970401940T 1991-02-12 1997-07-30 Beta-carboline derivatives, ligands of benzodiazepine receptors with inverse agonist and benzodiazepine antagonist effects and medicaments containing them GR3024291T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9101595A FR2672602B1 (fr) 1991-02-12 1991-02-12 Composes derives des beta-carbolines ligands du recepteur des benzodiazepines ayant un effet agoniste inverse et antagoniste vis-a-vis des benzodiazepines et medicaments les contenant.

Publications (1)

Publication Number Publication Date
GR3024291T3 true GR3024291T3 (en) 1997-10-31

Family

ID=9409607

Family Applications (1)

Application Number Title Priority Date Filing Date
GR970401940T GR3024291T3 (en) 1991-02-12 1997-07-30 Beta-carboline derivatives, ligands of benzodiazepine receptors with inverse agonist and benzodiazepine antagonist effects and medicaments containing them

Country Status (10)

Country Link
US (1) US5258385A (el)
EP (1) EP0499527B1 (el)
JP (1) JPH06211841A (el)
AT (1) ATE152452T1 (el)
CA (1) CA2061065A1 (el)
DE (1) DE69219379T2 (el)
DK (1) DK0499527T3 (el)
ES (1) ES2103904T3 (el)
FR (1) FR2672602B1 (el)
GR (1) GR3024291T3 (el)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW251284B (el) * 1992-11-02 1995-07-11 Pfizer
GB9503601D0 (en) 1995-02-23 1995-04-12 Merck Sharp & Dohme Method of treatment and method of manufacture of medicament
US20050113318A1 (en) * 2003-07-31 2005-05-26 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a beta-agonist bronchodilator for treatment of asthma or chronic obstructive pulmonary disease
US20050026884A1 (en) * 2003-07-31 2005-02-03 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a beta-agonist bronchodilator for treatment of asthma or chronic obstructive pulmonary disease
US20090285900A1 (en) * 2003-07-31 2009-11-19 Robinson Cynthia B Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a beta-agonist bronchodilator for treatment of asthma or chronic obstructive pulmonary disease

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3644384A (en) * 1969-06-09 1972-02-22 Sterling Drug Inc Certain 2-(alpha-haloacetyl) - 1 2 3 4-tetrahydro - 9h - pyrido(3 4-b)indole-3-carboxylates and derivatives
DE3608089A1 (de) * 1986-03-08 1987-09-10 Schering Ag Heteroaryl-oxy-ss-carbolinderivate, ihre herstellung und ihre verwendung als arzneimittel

Also Published As

Publication number Publication date
US5258385A (en) 1993-11-02
FR2672602A1 (fr) 1992-08-14
CA2061065A1 (fr) 1992-08-13
ES2103904T3 (es) 1997-10-01
EP0499527A1 (fr) 1992-08-19
ATE152452T1 (de) 1997-05-15
JPH06211841A (ja) 1994-08-02
DK0499527T3 (da) 1997-11-03
DE69219379D1 (de) 1997-06-05
DE69219379T2 (de) 1997-12-11
EP0499527B1 (fr) 1997-05-02
FR2672602B1 (fr) 1993-06-04

Similar Documents

Publication Publication Date Title
MX9202287A (es) Nuevos derivados de perhidroisoindol, procedimiento para su preparacion y composicion farmaceutica que los contiene.
BR1100931A (pt) Compostos derivados de aril-heteroaril carbinóis, processos para a preparação dos compostos, composições farmacêuticas, e, uso dos compostos derivados de aril-heteroaril carbinóis
ATE171188T1 (de) In 15-stellung substituierte 4-azasteroide
NZ244892A (en) 6-(1h-imidazol-1-ylmethyl)-2-phenylquinoline derivatives and pharmaceutical compositions
FI922983A (fi) Pyrimidin-4-karboxamidderivat, framstaellning av dessa och terapeutisk anvaendning av dessa
DE69515177D1 (de) Tetrahydropyridinylmethylderivate von pyrrolo[2,3-b]pyridine
GB9000301D0 (en) Piperidine & pyrrolidine derivatives
CA2129990A1 (en) Benzodiazepin derivatives useful as cck-receptor antagonists
GR3024291T3 (en) Beta-carboline derivatives, ligands of benzodiazepine receptors with inverse agonist and benzodiazepine antagonist effects and medicaments containing them
MA20857A1 (fr) Pyrrolo ( 1,2- a ) ( 4,1 ) benzoxazepines, procedes pour leur preparation.
GR3020292T3 (en) Use of 2-iminothiazolidin-4-one derivatives as new medicaments
KR880005134A (ko) 인돌로-피라지노-벤조 디아제민 유도체
DK179389D0 (da) Trienderivater indeholdende en chromenstruktur, fremgangsmaade til fremstilling heraf samt farmaceutiske midler indeholdende disse derivater
ZA914339B (en) ((1-arylpyrrolidin-2-yl)methyl)piperazine derivates,their preparation and their application in therapeutics
KR950702562A (ko) 항정신병제로서의 피리도인돌로벤조디아제핀 및 그의 유도체(pyridoindoloben zodiazepines and derivatives as antipsychotics)
ES2101620A1 (es) Nuevo compuesto derivado del cromeno.